LABORATORY CORPORATION OF AMERICA HOLDINGS

Andere Sprachen Laboratory Corporation of America Holdings

Aktien

895308

US50540R4092

LH

Markt geschlossen - Nyse Andere Börsenplätze 22:00:02 26.04.2024			% 5 Tage	% 1. Jan.
198.4 ^USD	+0.03%		-1.53%	-12.71%

26.04.	LABORATORY CORPORATION OF AMERICA HOLDINGS : erhält Kaufen-Rating von Baird	ZM
26.04.	LABORATORY CORPORATION OF AMERICA HOLDINGS : Barclays bleibt bei seiner Kaufempfehlung	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Laboratory Corp of America Q1 Adjusted Earnings, Revenue Increase; 2024 Adjusted EPS Outlook Updated	25.04.
Earnings Flash (LH) LABORATORY CORPORATION OF AMERICA HOLDINGS Reports Q1 Revenue $3.18B, vs. Street Est of $3.12B	25.04.
Earnings Flash (LH) LABORATORY CORPORATION OF AMERICA HOLDINGS Reports Q1 EPS $3.68, vs. Street Est of $3.48	25.04.
Labcorp: Q1 Earnings Snapshot	25.04.
Laboratory Corporation of America Holdings Reports Earnings Results for the First Quarter Ended March 31, 2024	25.04.
Labcorp beats quarterly estimates on strong testing demand	25.04.
Labcorp Announces 2024 First Quarter Results	25.04.
North American Morning Briefing : More Tech -2-	25.04.
Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln	25.04.
Labcorp Announces Winning Bid for Select Assets of Invitae	25.04.
Laboratory Corporation of America Holdings Announces Winning Bid for Select Assets of Invitae	25.04.
Invitae Enters into Agreement with Labcorp for Sale of Business	25.04.
Laboratory Corporation of America Holdings (NYSE:LH) won the bid to acquire substantially all of the assets of Invitae Corporation for approximately $240 million.	24.04.
Laboratory Corporation of America Holdings (NYSE:LH) agreed to acquire Substantially all Assets of Invitae Corporation for approximately $240 million.	24.04.
Labcorp Introduces Test for Early Detection of Neurodegenerative Diseases	15.04.
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw	15.04.
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw	15.04.
Labcorp Keeps Quarterly Dividend at $0.72 Per Share, Payable June 12 to Stockholders of Record May 28	11.04.
Labcorp Declares Quarterly Dividend	11.04.
Labcorp Declares Quarterly Dividend, Payable on June 12, 2024	11.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Laboratory Corporation of America Holdings

Aktien

895308

US50540R4092

LH

Andere Sprachen

Filter